General Biologicals Corporation (4117.TWO)
TWD 13.1
(2.75%)
TWD 13.1
(2.75%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 264.82 Million | 370.45 Million | 551.65 Million | 475.86 Million | 239.65 Million |
| Cost of Revenue | 202.11 Million | 198.6 Million | 269.72 Million | 224.81 Million | 112.81 Million |
| Gross Profit | 62.7 Million | 171.85 Million | 281.93 Million | 251.05 Million | 126.83 Million |
| Operating Expenses | 62.7 Million | 216.42 Million | 253.88 Million | 187.97 Million | 161.46 Million |
| Selling, General and Administrative Expenses | 203.41 Million | 180.57 Million | 219.64 Million | 146.84 Million | 125.56 Million |
| Research and Development Expenses | 33.1 Million | 35.85 Million | 34.24 Million | 41.13 Million | 35.8 Million |
| Other Expenses | - | 11.86 Million | 5.48 Million | 11.1 Million | - |
| Cost and Expenses | 434.76 Million | 415.03 Million | 523.6 Million | 412.78 Million | 274.27 Million |
| Operating Income | -169.93 Million | -32.97 Million | 33.86 Million | 71.32 Million | -34.53 Million |
| Interest Expense | 11.98 Million | 16.85 Million | 11 Million | 3.31 Million | 4.67 Million |
| Income Tax Expense | 12.12 Million | 7.69 Million | -5.47 Million | -13.79 Million | - |
| Earnings before Tax | -187.71 Million | -46.12 Million | 38.6 Million | 48.29 Million | -39.04 Million |
| Net Income | -198.83 Million | -53.19 Million | 44.14 Million | 62.15 Million | -39.04 Million |
| Earnings Per Share Basic | -3.32 | -0.89 | 0.74 | 1.18 | -0.99 |
| Earnings Per Share Diluted | -3.32 | -0.89 | 0.74 | 1.18 | -0.99 |
| Weighted Average Shares Outstanding | 59.82 Million | 59.82 Million | 59.82 Million | 52.74 Million | 39.47 Million |
| Weighted Average Shares Outstanding (Diluted) | 59.82 Million | 59.82 Million | 59.9 Million | 52.81 Million | 39.47 Million |
| Gross Margin | 0.24 | 0.46 | 0.51 | 0.53 | 0.53 |
| EBIT Margin | -0.50 | 0.01 | 0.13 | 0.21 | -0.06 |
| Profit Margin | -0.75 | -0.14 | 0.08 | 0.13 | -0.16 |
| EBITDA | -132.12 Million | 7.98 Million | 69.6 Million | 102.23 Million | -15.07 Million |
| Earnings Before Tax Margin | -0.64 | -0.09 | 0.06 | 0.15 | -0.14 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 55.63 Million | 55.63 Million | 65.56 Million | 264.82 Million | 65.56 Million | 66.84 Million |
| Cost of Revenue | 48.85 Million | 48.85 Million | 45.48 Million | 202.11 Million | 45.48 Million | 55.57 Million |
| Gross Profit | 6.78 Million | 6.78 Million | 20.08 Million | 62.7 Million | 20.08 Million | 11.27 Million |
| Operating Expenses | 55.14 Million | 57.01 Million | 65.69 Million | 236.52 Million | 65.69 Million | 54.85 Million |
| Selling, General and Administrative Expenses | 42.47 Million | 42.47 Million | 52.45 Million | - | 52.45 Million | 47.31 Million |
| Research and Development Expenses | 13.64 Million | 12.66 Million | 10.65 Million | - | 10.65 Million | 7.83 Million |
| Other Expenses | -974.5 Thousand | - | - | -1.52 Million | - | - |
| Cost and Expenses | 104 Million | 105.87 Million | 111.18 Million | 438.64 Million | 111.18 Million | 110.43 Million |
| Operating Income | -48.36 Million | -48.36 Million | -41.09 Million | -179.61 Million | -41.09 Million | -43.87 Million |
| Interest Expense | - | - | - | 11.98 Million | - | - |
| Income Tax Expense | 73 Thousand | 73 Thousand | 4.19 Million | 12.12 Million | 4.19 Million | 1.87 Million |
| Earnings before Tax | -52.98 Million | -52.98 Million | -47.83 Million | -187.71 Million | -47.83 Million | -46.02 Million |
| Net Income | -53 Million | -53 Million | -51.64 Million | -198.83 Million | -51.64 Million | -47.77 Million |
| Earnings Per Share Basic | -0.89 | -0.89 | -0.86 | - | -0.86 | -0.80 |
| Earnings Per Share Diluted | -0.89 | -0.89 | -0.86 | - | -0.86 | -0.80 |
| Weighted Average Shares Outstanding | 59.82 Million | 59.89 Million | 59.82 Million | 59.82 Million | 59.82 Million | 59.71 Million |
| Weighted Average Shares Outstanding (Diluted) | 59.82 Million | 59.89 Million | 59.82 Million | 59.82 Million | 59.82 Million | 59.82 Million |
| Gross Margin | 0.12 | 0.12 | 0.31 | 0.24 | 0.31 | 0.17 |
| EBIT Margin | -0.78 | -0.70 | -0.54 | - | -0.54 | -0.60 |
| Profit Margin | -0.95 | -0.95 | -0.79 | -0.75 | -0.79 | -0.71 |
| EBITDA | -43.43 Million | -39.07 Million | -35.15 Million | - | -35.15 Million | -40.03 Million |
| Earnings Before Tax Margin | -0.87 | -0.87 | -0.63 | -0.68 | -0.63 | -0.66 |
RCGCF
KRAS
PGCMF
GNSMF
002164
001319